Table 3 Pharmacokinetic parameters of Recombinant insulin lisargine solution and Lantus (insulin glargine).
From: X-ray crystallography reveals insulin lisargine structure and mechanisms of glucose regulation
Dosing Group | Dose (IU/kg) | AUC 0-t (mU·h/mL) | Cmax (mU/mL) | Tmax (h) |
---|---|---|---|---|
Recombinant Insulin Lisargine Solution | 0.5 | 3.48 ± 1.21 | 2.15 ± 0.93 | 1.10 ± 0.32 |
1 | 13.88 ± 2.49 | 7.73 ± 2.15 | 1.00 ± 0.00 | |
1.5 | 83.66 ± 17.10 | 26.34 ± 7.55 | 1.56 ± 0.53 | |
Lantus (Control) | 1.5 | 62.94 ± 13.83 | 15.95 ± 8.19 | 1.90 ± 0.88 |